RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...
Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...
CVS Health will report earnings on Wednesday morning, weeks after dumping its CEO in a desperate effort to reassure investors ...
The Associated Press - Business News on MSN9d
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giantCVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...
RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.
CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured ...
Among the gains in the contract are the elimination of two-tier wage scale and an increased health care bonus.
The new voicemail that was added 4-6 weeks back is totally unacceptable and CVS should be embarrassed of themselves. It’s a horrendous disease that came in and negatively infected the system ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback